THE ANTITHROMBOTIC AND BLEEDING EFFECTS OF DABIGATRAN, A DIRECT THROMBIN INHIBITOR, AS COMPARED TO ENOXAPARIN, HEPARIN AND WARFARIN IN RATS

被引：0
|
作者：
Van Ryn, J. [1 ]
Kuritsch, I. [1 ]
Kink-Eiband, M. [1 ]
Priepke, H. [1 ]
Wienen, W. [1 ]
机构：
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1011
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [31] THROMBIN INHIBITION COMPARED WITH OTHER ANTITHROMBOTIC DRUGS IN RATS
    SCHUMACHER, WA
    HERAN, CH
    STEINBACHER, TE
    MEGILL, JR
    BIRD, JE
    GIANCARLI, MR
    DURHAM, SK
    THROMBOSIS RESEARCH, 1992, 68 (02) : 157 - 166
  • [32] A proposed mechanism for reduced bleeding of direct thrombin inhibitors as compared to heparin as measured by thromboelastography.
    Yonekawa, KE
    Nagakawa, PA
    Nugent, DJ
    Young, G
    BLOOD, 2002, 100 (11) : 128B - 128B
  • [33] Comparative Antithrombotic and Antihemostatic Effects of the Direct Factor Xa Inhibitors, Apixaban and Rivaroxaban, and the Direct Thrombin Inhibitors, Dabigatran and Lepirudin, in Rabbit Models of Venous Thrombosis and Bleeding Time
    Wong, Pancras C.
    Crain, Earl, Jr.
    Watson, Carol
    BLOOD, 2008, 112 (11) : 1040 - 1041
  • [34] Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
    Bendel, Stephen D.
    Bona, Robert
    Baker, William L.
    ADVANCES IN THERAPY, 2011, 28 (06) : 460 - 472
  • [35] The direct factor Xa inhibitor apixaban produces broad antithrombotic activity with limited effects on bleeding time in rats
    Schumacher, William A.
    Bostwick, Jeffrey S.
    Stewart, Anne B.
    Steinbacher, Thomas E.
    Pinto, Donald J.
    Wong, Pancras C.
    BLOOD, 2007, 110 (11) : 69B - 69B
  • [36] Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
    Stephen D. Bendel
    Robert Bona
    William L. Baker
    Advances in Therapy, 2011, 28 : 460 - 472
  • [37] A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement:: the BISTRO II randomized trial
    Eriksson, BI
    Dahl, OE
    Büller, HR
    Hettiarachchi, R
    Rosencher, N
    Bravo, ML
    Ahnfelt, L
    Piovella, F
    Stangier, J
    Kälebo, P
    Reilly, P
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) : 103 - 111
  • [38] Development of dabigatran etexilate: A direct, reversible, oral thrombin inhibitor
    Wood, Susan
    van Ryn, Joanne
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [39] The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
    Blech, Stefan
    Ebner, Thomas
    Ludwig-Schwellinger, Eva
    Stangier, Joachim
    Roth, Willy
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (02) : 386 - 399
  • [40] Implications of Dabigatran, a Direct Thrombin Inhibitor, for Oral Surgery Practice
    Davis, Clayton
    Robertson, Chad
    Shivakumar, Sudeep
    Lee, Min
    JOURNAL OF THE CANADIAN DENTAL ASSOCIATION, 2013, 79
12345